| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 104,6 M € | +8.7% | 96,2 M € | +3.7% | 92,8 M € | -0.2% | 93,0 M € | +2.9% | 90,4 M € | +7.4% | 84,1 M € | +4.2% | 80,7 M € | +7.1% | 75,4 M € | +30.3% | 57,9 M € | +5.0% | 55,1 M € | -24.5% | 73,0 M € | +15.2% | 63,4 M € | +23.1% | 51,5 M € | +10.3% | 46,7 M € | -4.4% | 48,8 M € | +10.6% | 44,2 M € | +3.6% | 42,6 M € | +12.9% | 37,8 M € | |
| EBITDA | 39,4 M € | +36.7% | 28,8 M € | -8.2% | 31,4 M € | -1.6% | 31,9 M € | +6.0% | 30,1 M € | +42.9% | 21,0 M € | +25.2% | 16,8 M € | +4.7% | 16,1 M € | +58.0% | 10,2 M € | +7.2% | 9,5 M € | -56.1% | 21,6 M € | +80.0% | 12,0 M € | +77.1% | 6,8 M € | -16.1% | 8,1 M € | -10.9% | 9,1 M € | +28.8% | 7,0 M € | +16.7% | 6,0 M € | +22.3% | 4,9 M € | |
| Operating profit | 36,1 M € | +51.2% | 23,9 M € | -9.8% | 26,5 M € | -4.2% | 27,6 M € | -0.6% | 27,8 M € | +42.0% | 19,6 M € | +24.6% | 15,7 M € | +1.5% | 15,5 M € | +56.7% | 9,9 M € | +7.7% | 9,2 M € | -56.8% | 21,2 M € | +81.9% | 11,7 M € | +79.8% | 6,5 M € | -17.0% | 7,8 M € | -4.7% | 8,2 M € | +20.0% | 6,8 M € | +17.1% | 5,8 M € | +22.9% | 4,8 M € | |
| Profit/loss | 35,1 M € | +1.9% | 34,5 M € | -38.6% | 56,1 M € | +155.7% | 21,9 M € | -0.9% | 22,1 M € | +49.4% | 14,8 M € | +60.6% | 9,2 M € | -8.2% | 10,1 M € | +55.2% | 6,5 M € | +12.6% | 5,8 M € | -61.6% | 15,0 M € | +80.4% | 8,3 M € | +83.6% | 4,5 M € | -19.5% | 5,6 M € | +24.3% | 4,5 M € | +7.4% | 4,2 M € | -7.9% | 4,6 M € | +30.3% | 3,5 M € | |
| Equity | 212,9 M € | +3.5% | 205,6 M € | +12.8% | 182,4 M € | +20.6% | 151,2 M € | +17.0% | 129,3 M € | +20.7% | 107,2 M € | +15.3% | 92,9 M € | +11.0% | 83,7 M € | +13.7% | 73,6 M € | +9.6% | 67,2 M € | +9.4% | 61,4 M € | +32.3% | 46,4 M € | +20.5% | 38,5 M € | +13.3% | 34,0 M € | +19.8% | 28,4 M € | +19.0% | 23,9 M € | +21.4% | 19,6 M € | +30.3% | 15,1 M € | |
| Total assets | 241,9 M € | +11.7% | 216,6 M € | +13.1% | 191,6 M € | +8.0% | 177,3 M € | +7.5% | 165,0 M € | +21.7% | 135,6 M € | +25.9% | 107,6 M € | +10.6% | 97,3 M € | +10.0% | 88,5 M € | +14.4% | 77,3 M € | +1.6% | 76,1 M € | +26.3% | 60,3 M € | +15.6% | 52,2 M € | +12.1% | 46,5 M € | +5.1% | 44,3 M € | +20.4% | 36,7 M € | +34.3% | 27,4 M € | -2.0% | 27,9 M € | |
| Cash | 41,2 M € | +319.8% | 9,8 M € | -80.0% | 49,1 M € | +25.7% | 39,1 M € | +10.3% | 35,4 M € | +34.7% | 26,3 M € | -7.6% | 28,4 M € | -7.0% | 30,6 M € | +15.4% | 26,5 M € | -30.6% | 38,2 M € | +86.9% | 20,4 M € | +45.6% | 14,0 M € | -4.6% | 14,7 M € | +65.0% | 8,9 M € | +72.9% | 5,1 M € | -14.9% | 6,0 M € | +1744.8% | 327,9 k € | -61.5% | 851,3 k € | |
| Debts | 28,2 M € | +168.3% | 10,5 M € | +18.2% | 8,9 M € | -65.6% | 25,8 M € | -27.0% | 35,3 M € | +25.7% | 28,1 M € | +97.6% | 14,2 M € | +21.1% | 11,7 M € | -21.0% | 14,9 M € | +48.8% | 10,0 M € | -32.2% | 14,7 M € | +8.8% | 13,6 M € | +2.5% | 13,2 M € | +9.1% | 12,1 M € | -21.6% | 15,5 M € | +24.0% | 12,5 M € | +71.1% | 7,3 M € | -37.4% | 11,6 M € | |
| Staff | 38,7 | 40,2 | 42,3 | 42,3 | 45,9 | 46,7 | 46,8 | 47 | 48,2 | 47,2 | 46,3 | 43,8 | 43,8 | 44,1 | 45 | 45,7 | 43,4 | 41,2 | ||||||||||||||||||
Public limited company · Molenbeek-Saint-Jean · incorporated on 29/11/1978 · 38,7 ETP
Public limited company profitable and well capitalised. Cash position rising (+319.8%).
Solid counterparty for a standard engagement.
LABORATOIRES S.M.B. is a Public limited company incorporated in 1978. Its main activity is: Manufacture of pharmaceutical preparations. Its registered office is in Molenbeek-Saint-Jean. It employs on average 38,7 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette